Milestone Pharmaceuticals (MIST)
Milestone Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
19.7M
Short interest
settlement 2026-10-15
18.7
Days to cover
+2.7 days vs prior
63.8%
Short share of volume
2026-11-02
6,070
Fails to deliver
settlement 2026-10-14
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in MIST is 19,710,285 shares, up 1,348,602 shares over the last month. Over the last 48 readings it ranged from 398,732 shares (14 February 2025) to 19,710,285 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 1.1M shares a day that is 18.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/mist" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 19,710,285 | +3.7% | 1,052,760 | 18.72 |
| 2026-09-30 | 19,009,468 | +3.5% | 1,189,684 | 15.98 |
| 2026-09-15 | 18,361,683 | +5.8% | 1,733,080 | 10.59 |
| 2026-08-31 | 17,362,761 | +4.4% | 1,530,579 | 11.34 |
| 2026-08-14 | 16,636,852 | +6.1% | 1,769,774 | 9.40 |
| 2026-07-31 | 15,685,890 | +7.5% | 1,234,112 | 12.71 |
| 2026-07-15 | 14,584,446 | +15.8% | 1,073,499 | 13.59 |
| 2026-06-30 | 12,597,709 | +18.8% | 1,681,152 | 7.49 |
| 2026-06-15 | 10,604,847 | +15.4% | 1,220,711 | 8.69 |
| 2026-05-29 | 9,186,849 | +22.8% | 1,169,612 | 7.85 |
| 2026-05-15 | 7,484,287 | -4.2% | 1,754,038 | 4.27 |
| 2026-04-30 | 7,809,686 | -24.4% | 1,309,049 | 5.97 |
| 2026-04-15 | 10,325,577 | +22.1% | 3,686,839 | 2.80 |
| 2026-03-31 | 8,453,485 | -3.5% | 2,643,670 | 3.20 |
| 2026-03-13 | 8,758,410 | +4.0% | 1,294,910 | 6.76 |
| 2026-02-27 | 8,424,060 | +12.7% | 1,307,442 | 6.44 |
| 2026-02-13 | 7,474,168 | -22.1% | 2,061,707 | 3.63 |
| 2026-01-30 | 9,597,134 | +2.2% | 2,173,372 | 4.42 |
| 2026-01-15 | 9,389,788 | +13.8% | 3,848,434 | 2.44 |
| 2025-12-31 | 8,250,257 | +0.3% | 6,333,777 | 1.30 |
| 2025-12-15 | 8,222,765 | +11.3% | 12,175,867 | 1.00 |
| 2025-11-28 | 7,389,406 | +49.2% | 4,214,477 | 1.75 |
| 2025-11-14 | 4,953,316 | +8.7% | 1,914,637 | 2.59 |
| 2025-10-31 | 4,556,371 | -11.9% | 1,451,499 | 3.14 |
| 2025-10-15 | 5,173,005 | +2.9% | 1,494,820 | 3.46 |
| 2025-09-30 | 5,029,319 | -14.9% | 893,101 | 5.63 |
| 2025-09-15 | 5,912,759 | +9.3% | 1,241,692 | 4.76 |
| 2025-08-29 | 5,412,053 | -4.3% | 1,124,133 | 4.81 |
| 2025-08-15 | 5,656,083 | +0.0% | 832,694 | 6.79 |
| 2025-07-31 | 5,654,252 | +10.5% | 1,516,328 | 3.73 |
| 2025-07-15 | 5,115,566 | +160.0% | 3,871,141 | 1.32 |
| 2025-06-30 | 1,967,445 | -2.1% | 635,562 | 3.10 |
| 2025-06-13 | 2,009,988 | -5.1% | 625,093 | 3.22 |
| 2025-05-30 | 2,118,339 | +7.8% | 862,662 | 2.46 |
| 2025-05-15 | 1,965,048 | -16.9% | 1,085,573 | 1.81 |
| 2025-04-30 | 2,365,630 | -13.0% | 2,067,879 | 1.14 |
| 2025-04-15 | 2,718,305 | +6.1% | 1,906,996 | 1.43 |
| 2025-03-31 | 2,561,518 | +190.9% | 7,029,417 | 1.00 |
| 2025-03-14 | 880,568 | +18.6% | 1,676,959 | 1.00 |
| 2025-02-28 | 742,790 | +86.3% | 1,210,511 | 1.00 |
| 2025-02-14 | 398,732 | -17.2% | 864,660 | 1.00 |
| 2025-01-31 | 481,393 | -27.9% | 695,190 | 1.00 |
| 2025-01-15 | 667,868 | +31.0% | 690,458 | 1.00 |
| 2024-12-31 | 509,757 | -1.0% | 573,238 | 1.00 |
| 2024-12-13 | 514,782 | +11.9% | 436,407 | 1.18 |
| 2024-11-29 | 460,052 | +5.0% | 319,493 | 1.44 |
| 2024-11-15 | 438,272 | -3.6% | 687,905 | 1.00 |
| 2024-10-31 | 454,790 | +1.2% | 271,488 | 1.68 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of MIST volume is 63.8%, up 15.2 points over the last five sessions. Over the last 30 readings it ranged from 38.0% (13 October 2026) to 73.5% (14 October 2026). The latest reading is 9.3 points above the 30-session average of 54.4%, on 467K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 298K | 467K | 63.8% | 0 |
| 2026-10-30 | 179K | 387K | 46.4% | 0 |
| 2026-10-29 | 243K | 503K | 48.3% | 0 |
| 2026-10-28 | 292K | 532K | 54.8% | 0 |
| 2026-10-27 | 238K | 516K | 46.1% | 0 |
| 2026-10-26 | 239K | 493K | 48.5% | 225 |
| 2026-10-23 | 427K | 887K | 48.1% | 2,500 |
| 2026-10-22 | 125K | 291K | 43.1% | 0 |
| 2026-10-21 | 199K | 387K | 51.4% | 2 |
| 2026-10-20 | 154K | 336K | 45.7% | 800 |
| 2026-10-19 | 250K | 376K | 66.4% | 1,385 |
| 2026-10-16 | 263K | 634K | 41.4% | 12,143 |
| 2026-10-15 | 342K | 585K | 58.5% | 25 |
| 2026-10-14 | 342K | 466K | 73.5% | 0 |
| 2026-10-13 | 304K | 800K | 38.0% | 10 |
| 2026-10-12 | 430K | 763K | 56.4% | 0 |
| 2026-10-09 | 589K | 868K | 67.8% | 0 |
| 2026-10-08 | 621K | 931K | 66.7% | 500 |
| 2026-10-07 | 364K | 559K | 65.2% | 5 |
| 2026-10-06 | 536K | 856K | 62.6% | 0 |
| 2026-10-05 | 385K | 649K | 59.3% | 0 |
| 2026-10-02 | 260K | 547K | 47.6% | 50 |
| 2026-10-01 | 250K | 440K | 56.8% | 0 |
| 2026-09-30 | 452K | 853K | 53.0% | 0 |
| 2026-09-29 | 399K | 633K | 63.0% | 8,168 |
| 2026-09-28 | 123K | 247K | 50.0% | 0 |
| 2026-09-25 | 428K | 797K | 53.7% | 2,700 |
| 2026-09-24 | 779K | 1.4M | 54.2% | 6,065 |
| 2026-09-23 | 477K | 964K | 49.5% | 21,000 |
| 2026-09-22 | 706K | 1.3M | 53.4% | 11,048 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in MIST is 6,070 shares, up 1,581 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (28 August 2026) to 145,582 shares (21 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 6,070 | $0.77 | $5K |
| 2026-10-08 | 4,489 | $0.76 | $3K |
| 2026-10-07 | 1,395 | $0.76 | $1K |
| 2026-10-05 | 7,845 | $0.81 | $6K |
| 2026-10-02 | 38,220 | $0.82 | $31K |
| 2026-10-01 | 10,268 | $0.87 | $9K |
| 2026-09-30 | 2,976 | $0.82 | $2K |
| 2026-09-28 | 83,511 | $0.79 | $66K |
| 2026-09-25 | 97,011 | $0.79 | $77K |
| 2026-09-24 | 39,829 | $0.86 | $34K |
| 2026-09-23 | 98,537 | $0.92 | $91K |
| 2026-09-17 | 228 | $0.89 | $203 |
| 2026-09-16 | 807 | $0.93 | $751 |
| 2026-09-15 | 15,128 | $0.95 | $14K |
| 2026-09-14 | 57,424 | $0.98 | $56K |
| 2026-09-11 | 1,778 | $1.05 | $2K |
| 2026-09-10 | 15,720 | $1.07 | $17K |
| 2026-09-09 | 1,458 | $1.13 | $2K |
| 2026-09-08 | 19,643 | $1.20 | $24K |
| 2026-09-03 | 91,301 | $1.18 | $108K |
| 2026-09-02 | 79,995 | $1.14 | $91K |
| 2026-09-01 | 27,427 | $1.16 | $32K |
| 2026-08-31 | 20,410 | $1.16 | $24K |
| 2026-08-28 | 3 | $1.19 | $4 |
| 2026-08-25 | 60,485 | $1.04 | $63K |
| 2026-08-21 | 145,582 | $1.03 | $150K |
| 2026-08-18 | 1,043 | $1.10 | $1K |
| 2026-08-14 | 86,918 | $1.07 | $93K |
| 2026-08-12 | 44,291 | $1.27 | $56K |
| 2026-08-11 | 17,379 | $1.26 | $22K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for MIST in the last 90 days. The most recent filings are listed below. Latest filing: Oliveto Joseph (President and CEO) on 2026-04-16.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | Oliveto Joseph | President and CEO | Sell | 37K | $2.26 | $82K | 446K |
| 2026-01-26 | Oliveto Joseph | President and CEO | Exercise or conversion | 67K | price not stated in the filing | not stated | 517K |
| 2026-01-26 | Oliveto Joseph | President and CEO | Sell | 35K | $1.93 | $67K | 483K |
| 2026-01-26 | Hasija Amit | CFO & EVP of Corp. Development | Exercise or conversion | 20K | price not stated in the filing | not stated | 112K |
| 2026-01-26 | Hasija Amit | CFO & EVP of Corp. Development | Sell | 12K | $1.93 | $24K | 100K |
| 2026-01-26 | Muller Lorenz | Chief Commercial Officer | Sell | 11K | $1.93 | $22K | 205K |
| 2026-01-26 | Muller Lorenz | Chief Commercial Officer | Exercise or conversion | 20K | price not stated in the filing | not stated | 217K |
| 2026-01-26 | Nelson Jeffrey Edward | Chief Operating Officer | Sell | 12K | $1.93 | $24K | 50K |
| 2026-01-26 | Nelson Jeffrey Edward | Chief Operating Officer | Exercise or conversion | 20K | price not stated in the filing | not stated | 62K |
| 2026-01-26 | Bharucha David | Chief Medical Officer | Exercise or conversion | 20K | price not stated in the filing | not stated | 125K |
| 2026-01-26 | Bharucha David | Chief Medical Officer | Sell | 12K | $1.93 | $24K | 113K |
| 2026-01-08 | Oliveto Joseph | President and CEO | Sell | 43K | $2.25 | $97K | 304K |
| 2026-01-07 | Oliveto Joseph | President and CEO | Sell | 500 | $2.25 | $1K | 347K |
| 2025-12-15 | Oliveto Joseph | President and CEO | Sell | 133K | $2.32 | $309K | 451K |
| 2025-12-15 | Hasija Amit | CFO & EVP of Corp. Development | Sell | 58K | $2.32 | $135K | 92K |
| 2025-12-15 | Muller Lorenz | Chief Commercial Officer | Sell | 54K | $2.32 | $124K | 196K |
| 2025-12-15 | Nelson Jeffrey Edward | Chief Operating Officer | Sell | 58K | $2.32 | $135K | 42K |
| 2025-12-15 | Bharucha David | Chief Medical Officer | Sell | 58K | $2.32 | $135K | 105K |
| 2025-12-12 | Oliveto Joseph | President and CEO | Grant | 280K | price not stated in the filing | not stated | 584K |
| 2025-12-12 | Hasija Amit | CFO & EVP of Corp. Development | Grant | 100K | price not stated in the filing | not stated | 150K |
| 2025-12-12 | Muller Lorenz | Chief Commercial Officer | Grant | 100K | price not stated in the filing | not stated | 250K |
| 2025-12-12 | Nelson Jeffrey Edward | Chief Operating Officer | Grant | 100K | price not stated in the filing | not stated | 100K |
| 2025-12-12 | Bharucha David | Chief Medical Officer | Grant | 100K | price not stated in the filing | not stated | 163K |
| 2025-12-09 | Muller Lorenz | Chief Commercial Officer | Gift | 25K | $0.00 | $0 | 150K |
| 2025-07-11 | PAPA JOSEPH C | Director | Grant | 100K | price not stated in the filing | not stated | 100K |
| 2025-07-11 | Muller Lorenz | Chief Commercial Officer | Grant | 67K | price not stated in the filing | not stated | 175K |
| 2025-07-11 | Oliveto Joseph | President and CEO | Grant | 67K | price not stated in the filing | not stated | 347K |
| 2025-07-11 | Bharucha David | Chief Medical Officer | Grant | 53K | price not stated in the filing | not stated | 63K |
| 2025-07-11 | Wills Robert James | Director | Grant | 50K | price not stated in the filing | not stated | 65K |
| 2025-07-11 | Hasija Amit | CFO & EVP of Corp. Development | Grant | 50K | price not stated in the filing | not stated | 50K |
| 2025-07-11 | Liebert Debra K. | Director | Grant | 17K | price not stated in the filing | not stated | 17K |
| 2023-03-22 | WONG RODERICK | TenPercentOwner | Other transaction | 1.1M | price not stated in the filing | not stated | 3.3M |
| 2022-12-05 | Bharucha David | Chief Medical Officer | Buy | 7K | $4.69 | $33K | 10K |
| 2022-12-01 | Bharucha David | Chief Medical Officer | Buy | 3K | $4.86 | $15K | 3K |
| 2022-10-21 | Liebert Debra K. | Director | Buy | 4K | $5.26 | $21K | 4K |
| 2022-10-20 | Liebert Debra K. | Director | Buy | 10K | $5.29 | $53K | 10K |
| 2022-10-20 | Pasternak Richard C | Director | Buy | 10K | $5.20 | $52K | 10K |
| 2022-10-19 | TOMSICEK MICHAEL JOHN | Director | Buy | 15K | $5.32 | $80K | 15K |
| 2022-10-19 | Wills Robert James | Director | Buy | 15K | $4.93 | $74K | 15K |
| 2022-09-14 | Liebert Debra K. | Director | Other transaction | 127 | $0.00 | $0 | 127 |
| 2022-09-07 | RTW INVESTMENTS, LP | TenPercentOwner | Sell | 1.6M | $8.71 | $13.6M | 4.3M |
| 2022-09-07 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 1.6M | $8.71 | $13.6M | 4.3M |
| 2022-05-31 | TRUEX PAUL F | Director | Exercise or conversion | 8K | $1.12 | $9K | 8K |
| 2022-05-31 | TRUEX PAUL F | Director | Exercise or conversion | 45K | $1.54 | $69K | 53K |
| 2022-05-31 | TRUEX PAUL F | Director | Exercise or conversion | 23K | $1.54 | $35K | 76K |
| 2022-05-31 | TRUEX PAUL F | Director | Exercise or conversion | 822 | $2.66 | $2K | 77K |
| 2022-05-31 | TRUEX PAUL F | Director | Buy | 5K | $5.60 | $28K | 82K |
| 2020-08-26 | Muller Lorenz | Chief Commercial Officer | Exercise or conversion | 6K | $1.54 | $9K | 108K |
| 2020-07-29 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | TenPercentOwner | Sell | 500K | $8.32 | $4.2M | 2.3M |
| 2020-07-28 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | TenPercentOwner | Sell | 20K | $8.10 | $161K | 2.8M |
| 2020-04-03 | Muller Lorenz | Chief Commercial Officer | Exercise or conversion | 33K | $1.54 | $50K | 85K |
| 2020-04-03 | Muller Lorenz | Chief Commercial Officer | Exercise or conversion | 18K | $1.54 | $28K | 103K |
| 2020-03-19 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 6K | $10.87 | $64K | 4.3M |
| 2020-03-18 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 3K | $10.36 | $28K | 4.3M |
| 2020-03-02 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 78K | $18.95 | $1.5M | 4.3M |
| 2020-01-13 | WONG RODERICK | TenPercentOwner | Buy | 270K | $16.25 | $4.4M | 4.2M |
| 2019-12-31 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 21K | $15.50 | $332K | 4.0M |
| 2019-12-30 | RTW INVESTMENTS, LP | TenPercentOwner | Buy | 1K | $15.48 | $21K | 3.9M |
| 2019-12-21 | Oliveto Joseph | President and CEO | Exercise or conversion | 7K | $1.54 | $11K | 281K |
| 2019-10-01 | Muller Lorenz | Chief Commercial Officer | Exercise or conversion | 3K | $1.54 | $4K | 52K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for MIST worth $252K at the prices reported; 0 in the last 90 days worth $0. Latest: JOSEPH OLIVETO filed on 2026-04-16 to sell 36,500 shares ($80K) from 2026-04-16.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-04-16 | JOSEPH OLIVETODirector, Officer | 37K | $80K | 0.031% | 2026-04-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-08 | JOSEPH OLIVETODirector, Officer | 80K | $171K | 0.093% | 2026-01-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-07 | JOSEPH OLIVETOOfficer | 500 | $1K | 0.001% | 2026-01-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON12 holders report 5% or more of MIST in their latest filing, all on Schedule 13G (passive). The largest reported stake is RTW Investments, LP at 9.9% of the class (12,356,953 shares), filed 2026-05-15 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-07 | 13G | Pavaki Capital Management LLCinvestment adviser | 9.1M | 7.3% | 2025-12-31 |
| 2026-08-07 | 13G | Pavaki Capital Partners, LPpartnership | 9.1M | 7.3% | 2025-12-31 |
| 2026-08-07 | 13G | Ashok Rambhai Patelindividual, parent holding company | 9.1M | 7.3% | 2025-12-31 |
| 2026-05-15 | 13G/Ano. 7 | RTW Investments, LPinvestment adviser, partnership | 12.4M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Roderick Wongparent holding company, individual | 12.4M | 9.9% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 8.0M | 6.4% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 8.0M | 6.4% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 8.0M | 6.4% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 2 | Trails Edge Capital Partners, LPinvestment adviser, partnership | 5.3M | 4.3% | 2026-03-20 |
| 2026-03-26 | 13G/Ano. 2 | Trails Edge Biotechnology Master Fund, LPpartnership | 5.3M | 4.3% | 2026-03-20 |
| 2026-03-26 | 13G/Ano. 2 | Ortav Yehudaiindividual | 5.3M | 4.3% | 2026-03-20 |
| 2025-12-23 | 13G | Propel Bio Management, LLCinvestment adviser | 8.9M | 9.9% | 2025-07-11 |
| 2025-12-23 | 13G | Leen Kawasindividual | 8.9M | 9.9% | 2025-07-11 |
| 2025-12-23 | 13G | Richard Kayneindividual | 8.9M | 9.9% | 2025-07-11 |
| 2025-12-23 | 13G | Propel Bio Partners LLCother entity | 8.9M | 9.9% | 2025-07-11 |
13F holders
Tracked managers holding MIST at their latest 13F. JSON4 of the 30 tracked managers held MIST at their latest 13F, $14.2M in total at quarter-end prices. Point72 Asset Management is the largest at $7.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 5.4M | $7.3M | 0.01% | +4.3M |
| Millennium Management | 2026-06-30 | 3.1M | $4.2M | 0.00% | +1.6M |
| Two Sigma Investments | 2026-06-30 | 2.0M | $2.7M | 0.00% | -277K |
| Citadel Advisors | 2026-06-30 | 33K | $44K | 0.00% | -164K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Milestone Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Milestone Pharmaceuticals (MIST), SEC CIK 1408443, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-04-16.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-04-16.JSON and CSV
- Company record
- EDGAR filing index for CIK 1408443Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of MIST is sold short?
19,710,285 shares were held short at the 2026-10-15 settlement, 18.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is MIST's daily short volume?
On 2026-11-02, 297,547 of the 466,534 MIST shares reported to FINRA were sold short, 63.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does MIST have fails to deliver?
The SEC's latest file shows 6,070 MIST shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are MIST insiders buying or selling?
No open-market insider trades were reported for MIST in the last 90 days. The most recent filings are listed below. Latest filing: Oliveto Joseph (President and CEO) on 2026-04-16.
Have MIST insiders filed to sell?
3 Form 144 notices on file for MIST worth $252K at the prices reported; 0 in the last 90 days worth $0. Latest: JOSEPH OLIVETO filed on 2026-04-16 to sell 36,500 shares ($80K) from 2026-04-16.
Who owns 5% or more of MIST?
12 holders report 5% or more of MIST in their latest filing, all on Schedule 13G (passive). The largest reported stake is RTW Investments, LP at 9.9% of the class (12,356,953 shares), filed 2026-05-15 for an event on 2026-03-31.
Which tracked 13F managers own MIST?
4 of the 30 tracked 13F managers held MIST shares at their latest filing, $14.2M in all. The largest: Steve Cohen's Point72 Asset Management (5.4M shares, $7.3M), Izzy Englander's Millennium Management (3.1M shares, $4.2M), Two Sigma Investments (2.0M shares, $2.7M), Ken Griffin's Citadel Advisors (33K shares, $44K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.